Latest Strategic Planning News

McLaren Minerals has completed its Phase 1 drilling program at the McLaren Titanium Project, revealing significant extensions to its mineral sands resource and setting the stage for future growth.

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.

First Au Limited’s trading suspension has been lifted following its announcement of a significant gold asset acquisition, signaling renewed market activity for the miner.

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.

Webjet Group Limited reported a stable FY25 EBITDA of $39.4 million despite a 7% decline in bookings driven by soft domestic flight demand. Growth in international bookings and strategic investments underpin a confident outlook.

Webjet Group Limited reports resilient FY25 results following its recent demerger, with a strategic plan to double transaction value by FY30. Despite macroeconomic headwinds, the company maintains strong cash reserves and outlines ambitious growth initiatives.

Albion Resources has identified three promising gold drill targets at its Barwidgee prospect in Western Australia, setting the stage for its maiden drilling campaign in June 2025. These targets are supported by recent geophysical and geochemical surveys indicating potential gold-related sulphide mineralisation.

Domino’s Pizza Enterprises announces the departure of long-serving ANZ CEO Kerri Hayman in August 2025, with Greg Steenson appointed as the new Chief Operating Officer to lead the next growth phase.

Gentrack Group Limited reported a solid 9.8% revenue increase and a 34.7% jump in net profit for the first half of 2025, yet opted against paying an interim dividend.

Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.

Ballymore Resources has reported exceptional high-grade gold intersections from its ongoing Stage 5 underground drilling at the Dittmer Project, reinforcing the potential of a large gold system in North Queensland.

Universal Biosensors reports solid growth in its wine testing segment and outlines plans for a capital raise alongside the upcoming AQUASCOUT water testing device launch.